Below are select transactions in power and life sciences completed over David Madden’s career, both in-company and as a consultant.

VENTURE

Life Sciences

• Mellitus, LLC, Boston, Massachusetts:  $4M in convertible debt
• Vaxart, Inc., San Francisco, California:  $3.1 million Series B extension, $20 million Series C
• XDx, Inc., Brisbane, California:  $15 million senior debt refinancing and upsizing
• AiroMedica LLC, Oakland, California: Founding partner
• CoNCERT Pharmaceuticals, Inc., Lexington, Massachusetts: Advised investor on participation in Series C investment
• 7TM Pharma A/S, Hørsholm, Denmark: Advised lead on late series investment
• Syntaxin Ltd., Abingdon, United Kingdom: Advised co-lead on Series B investment

TURNAROUND

Life Sciences

• Arriva Pharmaceuticals, Alameda, California: Led financial side of a successful Chapter 11 bankruptcy providing full discharge from liabilities and containment of damages from outstanding litigation

ACQUISITIONS

Life Sciences

• PowderJect Pharmaceuticals, Oxford, United Kingdom: Acquisition of vaccine manufacturer for approximately $878 million; post-merger integration
• Sagres Discovery, Davis, California: Acquisition of a venture-funded research company for approximately $12 million
• Matrix Pharmaceuticals, Fremont, California: Acquisition of oncology drug development company for $61 million; post-merger integration

Power

• New England Power Company, Westborough, Massachusetts: Acquisition of non-nuclear generation assets for approximately $2.5 billion of consideration
• Ormesa II, El Centro, California: Acquisition of geothermal facility; post-merger integration

DEVELOPMENT

Life Sciences

• License from Intercell AG to market its Japanese Encephalitis vaccine
• Probe-based HCV and HIV clinical diagnostics: Worldwide license granted to F. Hoffman-La Roche in settlement of litigation
• Probe-based HCV and HIV blood screening: Worldwide license granted to F. Hoffman-La Roche in settlement of litigation
• Probe-based HIV clinical diagnostics: Worldwide license granted to Organon Teknika
• Men C vaccine: Canadian distribution agreement signed with Merck Frosst
• HCV Vaccines: Early phase collaboration agreement with CSL of Australia

Power

• Rocksavage, Runcorn, United Kingdom: Greenfield gas-fired generation facility
• Dabhol, India: Gas-fired generation facility
• National Power Company, Oakland, California: Formation of company
• GWF, Walnut Creek, California: Seven generation facilities, mostly waste-fuel-fired